Astec Lifesciences Ltd reported the outcome of its Board Meeting held on October 29, 2025, where the Board approved the unaudited financial results for the quarter and half year ending September 30, 2025, reflecting a total net profit after tax from subsidiaries ranging from Rs. 2.91 lakhs to Rs. 6.09 lakhs, with unmodified opinions from auditors on results.